Trial Profile
Incidence of cardiovascular and cerebrovascular events associated with sirolimus use after liver transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2015
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Liver transplant rejection
- Focus Adverse reactions
- 02 Nov 2015 New trial record